Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
11
Number of overlapping holdings
22.9%
% of CANC's 48 holdings also in IDNA
23.9%
% of IDNA's 51 holdings also in CANC
Overlap by Weight
Sector Drift (CANC minus IDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in IDNA |
Overlap | |
|---|---|---|---|---|
 |
ASTRAZENECA PLC | 4.3% | 5.1% | 4.3% |
 |
EXELIXIS INC | 4.0% | 4.9% | 4.0% |
|
REVOLUTION MEDICINES, INC. | 5.4% | 3.7% | 3.7% |
|
ARCELLX, INC. | 3.0% | 3.8% | 3.0% |
|
MERCK & CO. INC. | 2.9% | 4.1% | 2.9% |
Position Highlights (Non-Overlapping Exposures)
CANC Overweight Relative to IDNA
|
ELI LILLY & CO | 5.3% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | 5.2% |
|
BRISTOL-MYERS SQUIBB CO | 4.5% |
|
NOVARTIS AG | 4.2% |
|
BRIDGEBIO PHARMA, INC. | 4.1% |
|
NUVALENT, INC. CLASS A | 3.8% |
 |
ZAI LAB LTD. UNSPONSORED ADR | 3.7% |
 |
GENMAB A/S SPONSORED ADR | 3.1% |
 |
MERUS N.V. | 3.1% |
|
SUMMIT THERAPEUTICS INC | 3.1% |
CANC Underweight Relative to IDNA
|
BEIGENE, LTD. | -6.2% |
|
ROCHE HOLDING LTD | -5.5% |
 |
SANOFI-AVENTIS | -5.4% |
|
GSK PLC | -5.3% |
|
SPRINGWORKS THERAPEUTICS, INC. | -5.0% |
 |
TAKEDA PHARMACEUTICAL CO LTD | -4.9% |
|
GENMAB A/S | -4.3% |
 |
BIONTECH SE SPONSORED ADR | -3.7% |
|
TWIST BIOSCIENCE CORP. | -3.6% |
|
MODERNA, INC. | -3.3% |